Status:
COMPLETED
Impact of Automated Education and Follow-up Mechanisms on Patient Engagement
Lead Sponsor:
Kaiser Permanente
Collaborating Sponsors:
ResMed
Conditions:
Obstructive Sleep Apnea
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The primary and well-known challenge with continuous positive airway pressure (CPAP) is the incomplete adherence of patients to this therapy. Successfully improving CPAP use is likely through emphasiz...
Detailed Description
Background Obstructive sleep apnea (OSA) is a prevalent condition which based on polysomnographic criteria affects 24% of men and 9% of women in the middle-aged population. Due to its high prevalence...
Eligibility Criteria
Inclusion
- Clinical suspicion of obstructive sleep apnea (OSA)
- Appropriate for home sleep testing
- No prior use of CPAP or other therapies for OSA
Exclusion
- Commercial drivers
- Complex sleep disorders (e.g. CSA)
- No DME (durable medical equipment) insurance coverage
- Declines CPAP therapy
Key Trial Info
Start Date :
November 1 2014
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 1 2016
Estimated Enrollment :
1873 Patients enrolled
Trial Details
Trial ID
NCT02279901
Start Date
November 1 2014
End Date
November 1 2016
Last Update
March 6 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Sleep Center; Fontana Medical Center, Kaiser Permanente
Fontana, California, United States, 92335